Stjärnkvist P, Degling L, Sjöholm I
Department of Drugs, National Board of Health and Welfare, Uppsala, Sweden.
J Pharm Sci. 1991 May;80(5):436-40. doi: 10.1002/jps.2600800508.
Polyacryl starch microparticles are being investigated for use as drug carriers, especially in the treatment of intracellular parasitic diseases. The purpose of this work was to investigate the possible immune response to drugs coupled to the microparticles, using the dinitrophenyl group (DNP) as a model. The humoral immunogenicity of DNP hapten-conjugated polyacryl starch microparticles has been examined in mice. Microparticle:hapten complexes with different biodegradability were tested, as well as different dosages and routes of administration. Two DNP derivatives, Lys(DNP) and Leu-Ala-Lys(DNP), were coupled to microparticles. It was shown that Lys(DNP) was released from the particles by lysosomal enzymes only from the conjugate with the tripeptide DNP derivative. The DNP conjugated to the particles via the biodegradable Leu-Ala-Lys arm induced only a weak immune response without memory. No response was detected after injection of the Lys(DNP) microparticles. Thus, there should be no major immunological obstacles in using drug:microparticle complexes in the treatment of, for example, parasitic diseases.
聚丙烯淀粉微粒正被研究用作药物载体,尤其是在治疗细胞内寄生虫病方面。这项工作的目的是使用二硝基苯基(DNP)作为模型,研究对与微粒偶联的药物可能产生的免疫反应。已在小鼠中检测了DNP半抗原偶联的聚丙烯淀粉微粒的体液免疫原性。测试了具有不同生物降解性的微粒:半抗原复合物,以及不同的剂量和给药途径。两种DNP衍生物,Lys(DNP)和Leu-Ala-Lys(DNP),与微粒偶联。结果表明,只有与三肽DNP衍生物的偶联物中的Lys(DNP)能被溶酶体酶从微粒中释放出来。通过可生物降解的Leu-Ala-Lys臂与微粒偶联的DNP仅诱导微弱的无记忆免疫反应。注射Lys(DNP)微粒后未检测到反应。因此,在使用药物:微粒复合物治疗例如寄生虫病时,应该不存在重大的免疫学障碍。